Metabolic gene expression-based stratification and prognostic risk predictive model of head and neck squamous cell carcinoma

Read full text Summarise with VIRAT
Authors: Soumya Sau, Anjali Gupta, Swastik Sinha, S. M. Azeem Mohiyuddin, Arvind M. Korwar
Cited by: 0
References: 83

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Head and neck squamous cell carcinoma (HNSCC) is a complex multivariable disease posing a significant challenge in therapeutics. OXPHOS and PPP are centrally implicated in metabolic heterogeneity influencing tumor behavior, treatment response, and patient outcomes. This study aims to stratify HNSCC based on OXPHOS and PPP gene expression to construct a clinical outcome risk predictive model. HNSCC patients were stratified into four metabolic subtypes including mixed, OXPHOS-leaning, PPP-leaning, and quiescent. The quiescent metabolic subtype showed longest survival with lower proliferation scores, whereas mixed subtype showed the worst survival with higher proliferation scores. Metabolic proteins of the CPTAC and ICPC cohorts affirmed the existence of metabolic heterogeneity among tumor samples. A prognostic risk predictive model was developed based on thirteen genes, which performed better than the OXPHOS-PPP-glycolysis model and other predictive forty-seven metabolic gene's model. Existence of metabolic heterogeneity was successfully determined in HNSCC. OXPHOS and PPP genes enriched in mixed metabolic subtype having the worst clinical outcome are suggestive of higher metastatic potential, which might offer advisement in personalized therapeutics.

Fields of Study & Subjects

Cancer Hypoxia and Metabolism Head and Neck Cancer Studies Ferroptosis and cancer prognosis

Publication details

Journal / source
npj Systems Biology and Applications
Volume
12
Issue
1
Publication date
25 March 2026
Language
EN